Infection and anti-tumor necrosis factor-alpha therapy.
Zandman-Goddard
Gisele
G
D000818:Animals; D000911:Antibodies, Monoclonal / Q000009:adverse effects; D018501:Antirheumatic Agents / Q000009:adverse effects*; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy; D006660:Histoplasmosis / Q000276:immunology; D006801:Humans; D000069285:Infliximab; D008088:Listeriosis / Q000276:immunology; D009894:Opportunistic Infections / Q000276:immunology*; D012216:Rheumatic Diseases / Q000150:complications / Q000188:drug therapy*; D014376:Tuberculosis / Q000276:immunology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab